ADRs and Pharmacovigilance

Centers for Education & Research on Therapeutics™

The material highlights the high burden of ADRs, including millions of serious events and substantial economic costs. It explains key pharmacovigilance activities such as spontaneous reporting, targeted spontaneous reporting, and active surveillance, outlining their purposes and limitations. The guide details the components of a valid ADR report and introduces causality assessment tools like the WHO and Naranjo scales. It also emphasizes the importance of education and clinical training in improving drug safety monitoring, particularly in the Ugandan context.